Apotex decision has ramifications for drug supply chain
20th April 2016
By David Rowley
The decision of a large player like Apotex to pull three products from the PBS has ramifications for the whole drug supply chain, says Generic and Biosimilar Medicines Association (GBMA) CEO Belinda Wood.